| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 31 |
| 1 | PANTOPRAZOLE | 26 |
| 2 | FAMOTIDINE | 20 |
| 3 | QUETIAPINE | 20 |
| 4 | ACETAMINOPHEN | 19 |
| 5 | ACETAMINOPHEN 500MG | 19 |
| 6 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 19 |
| 7 | PAIN RELIEVER | 19 |
| 8 | INFLIXIMAB | 18 |
| 9 | METOPROLOL | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERYTHROMYCIN AND BENZOYL PEROXIDE | 1 | 0.0062 |
| 1 | PRAMOXINE HYDROCHLORIDE, MENTHOL | 1 | 0.0047 |
| 2 | COLLOIDAL OATMEAL | 1 | 0.0039 |
| 3 | BELINOSTAT | 1 | 0.0028 |
| 4 | CEFADROXIL | 5 | 0.0025 |
| 5 | CYSTEAMINE BITARTRATE | 2 | 0.0019 |
| 6 | ELRANATAMAB-BCMM | 1 | 0.0009 |
| 7 | POTASSIUM ACETATE | 1 | 0.0007 |
| 8 | TALQUETAMAB-TGVS | 1 | 0.0007 |
| 9 | CASPOFUNGIN ACETATE | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 70 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 22 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 21 |
| 3 | Histamine-2 Receptor Antagonist [EPC] | 20 |
| 4 | Atypical Antipsychotic [EPC] | 17 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 17 |
| 6 | Opioid Agonist [EPC] | 17 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 14 |
| 8 | Benzodiazepine [EPC] | 13 |
| 9 | Proton Pump Inhibitor [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 5 | 0.0009 |
| 2 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 3 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 3 | 0.0003 |
| 5 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |
| 6 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 7 | Phenothiazine [EPC] | 5 | 0.0002 |
| 8 | Aluminum Complex [EPC] | 4 | 0.0002 |
| 9 | Histamine-2 Receptor Antagonist [EPC] | 20 | 0.0002 |